Position in AXSM
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$845,100
+$841,448 QoQ
Shares Held
5,000
+24900.0% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
10 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in AXSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Quarry LP holds $18,543,179 across 42 Biotechnology names. AXSM ranks #4 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
59,263 | $5,763,326 | |
| 2 | RNA |
Atrium Therapeutics, Inc.
|
66,651 | $891,123 | |
| 3 | PRAX |
Praxis Precision Medicines, Inc.
|
2,750 | $886,022 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
This page
|
5,000 | $845,100 | |
| 5 | KALV |
KalVista Pharmaceuticals, Inc.
|
33,750 | $679,387 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
46,220 | $668,341 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
10,000 | $564,900 | |
| 8 | VSTM |
Verastem, Inc.
|
100,000 | $530,000 |
All Filings in AXSM
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $845,100 | 5,000 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $3,652 | 20 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $151,812 | 1,250 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $260,975 | 2,500 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $163,282 | 1,400 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $63,457 | 750 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $179,740 | 2,000 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $257,600 | 3,200 | Shares | Other | 2024-08-16 | |
| 2024-03-31 | $143,640 | 1,800 | Shares | Other | 2024-05-15 | |
| 2023-09-30 | $121,958 | 1,745 | Shares | Other | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||